Adlai Nortye Ltd American Depositary Shares (ANL) Stock Price, Quote & News - Mboum

Company Profile

Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the t...

Industry: Biotechnology

Sector: Healthcare

Phone: 848 230 7430

Website: www.adlainortye.com

Address:

Ugland House, PO Box 309, Grand Cayman, Cayman Islands

Nios72 Jan. 14 at 4:48 PM

0 · Reply

Nios72 Jan. 13 at 8:35 PM

0 · Reply

Benamin38659 Jan. 13 at 8:18 PM

$ANL pipeline , updates Q1 2026 any day now

0 · Reply

Benamin38659 Jan. 13 at 7:53 PM

$ANL will it explode soon !

0 · Reply

Benamin38659 Jan. 13 at 4:44 PM

$ANL bullish

0 · Reply

Nios72 Jan. 12 at 9:11 PM

0 · Reply

Nios72 Jan. 12 at 5:43 PM

0 · Reply

Benamin38659 Jan. 12 at 2:47 PM

$ANL bullish

0 · Reply

Nios72 Jan. 9 at 9:01 PM

$ANL closing strong for the week. Let's do it again next week.

0 · Reply

Nios72 Jan. 9 at 3:57 PM

1 · Reply

Latest News on ANL

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China

Dec 29, 2025, 6:00 AM EST - 16 days ago

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China

Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 13, 2025, 11:07 PM EDT - 3 months ago

Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

May 23, 2024, 9:03 PM EDT - 1 year ago

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

May 22, 2024, 8:00 AM EDT - 1 year ago

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

Mar 29, 2024, 6:00 AM EDT - 1 year ago

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

Nov 17, 2023, 7:30 AM EST - 2 years ago

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

Oct 23, 2023, 8:12 AM EDT - 2 years ago

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles

Oct 13, 2023, 8:00 AM EDT - 2 years ago

Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

Oct 3, 2023, 12:05 PM EDT - 2 years ago

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline

Sep 30, 2023, 3:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline

BIRK KHIW LRE VSME

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

Sep 29, 2023, 2:46 AM EDT - 2 years ago

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: August Wraps Up With 1 Nano-Cap

Sep 3, 2023, 10:45 AM EDT - 2 years ago

U.S. IPO Weekly Recap: August Wraps Up With 1 Nano-Cap

ABNB ARM CART IPO IPOS IVP SNOW

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

Aug 12, 2023, 6:00 AM EDT - 2 years ago

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

FTEL NRXS NWGL VFS

IPO Update: Adlai Nortye Readies $72 Million U.S. IPO

Aug 11, 2023, 2:16 PM EDT - 2 years ago

IPO Update: Adlai Nortye Readies $72 Million U.S. IPO

Cancer treatment company Adlai Nortye sets terms in IPO

Aug 11, 2023, 7:05 AM EDT - 2 years ago

Cancer treatment company Adlai Nortye sets terms in IPO

Adlai Nortye Ltd. Begins U.S. IPO Rollout

Jul 31, 2023, 6:17 PM EDT - 2 years ago

Adlai Nortye Ltd. Begins U.S. IPO Rollout

Nios72 Jan. 14 at 4:48 PM

0 · Reply

Nios72 Jan. 13 at 8:35 PM

0 · Reply

Benamin38659 Jan. 13 at 8:18 PM

$ANL pipeline , updates Q1 2026 any day now

0 · Reply

Benamin38659 Jan. 13 at 7:53 PM

$ANL will it explode soon !

0 · Reply

Benamin38659 Jan. 13 at 4:44 PM

$ANL bullish

0 · Reply

Nios72 Jan. 12 at 9:11 PM

0 · Reply

Nios72 Jan. 12 at 5:43 PM

0 · Reply

Benamin38659 Jan. 12 at 2:47 PM

$ANL bullish

0 · Reply

Nios72 Jan. 9 at 9:01 PM

$ANL closing strong for the week. Let's do it again next week.

0 · Reply

Nios72 Jan. 9 at 3:57 PM

1 · Reply

Nios72 Jan. 9 at 2:52 PM

0 · Reply

Nios72 Jan. 9 at 2:45 AM

0 · Reply

XING851653619 Jan. 8 at 5:55 AM

$ANL 奥赛康药业宣布与阿诺医药达成战略合作，以超16亿元人民币(3500万元首付款+高达15.98亿元里程碑付款)的总对价，获得后者临床前泛RAS抑制剂AN9025在中国区域的独家权益。公告显示，AN9025项目是阿诺医药开发的新型口服泛RAS抑制剂，可用于治疗RAS突变型实体瘤，目前已在中国和美国完成新药临床试验申请(IND)，并已获得美国食品药品监督管理局(FDA)的临床试验批准，其亮点主要体现在靶向RAS“不可成药”靶点这一作用机制上。

1 · Reply

Ron_Burn Jan. 7 at 4:56 PM

$ANL feels like it has bottomed out. Let's see if she climbs above 1.6 within this week

0 · Reply

Nios72 Jan. 7 at 3:32 PM

0 · Reply

Nios72 Jan. 6 at 9:01 PM

$ANL 2 green days in row. Let's keep it going.

0 · Reply

Nios72 Jan. 5 at 4:44 PM

0 · Reply

XING851653619 Jan. 5 at 4:01 PM

$ANL 该公司即将收到3500万首付款

0 · Reply

Nios72 Jan. 5 at 2:35 PM

0 · Reply

hihi8088 Jan. 5 at 7:57 AM

$ANL another week of consecutive drops. Stay away from trash

0 · Reply

Kaz007 Jan. 5 at 4:10 AM

$ANL Where is hope?

0 · Reply

Nios72 Jan. 2 at 2:43 PM

0 · Reply